RecruitingPHASE2, PHASE3NCT06126315
Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Principal Investigator
- Elisabetta Pupillo, PharmDIstituto Di Ricerche Farmacologiche Mario Negri
- Intervention
- Acetyl-l-carnitine(drug)
- Enrollment
- 246 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2027
Study locations (19)
- Concord Hospital, Sydney, Australia
- Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Dipartimento di Neurologia, Bergamo, Italy
- Fondazione Serena ONLUS Centro Clinico NEMO Brescia, Brescia, Italy
- Istituto Auxologico Italiano, IRCCS Dipartimento di Neurologia, Milan, Italy
- Fondazione Serena ONLUS centro clinico NEMO, Milan, Italy
- AOU di Modena Nuovo Ospedale Civile S. Agostino Estense di Modena - Ospedale di Baggiovara, Modena, Italy
- Azienda Ospedaliera Universitaria Federico II Di Napoli, Naples, Italy
- Azienda Ospedaliera Universitaria "Luigi Vanvitelli", Dipartimento di Scienze mediche e chirurgiche avanzate, Naples, Italy
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
- Azienda Ospedale-Università di Padova, Unità di Neurologia Clinica, Padova, Italy
- A.S.P. Palermo, Villa delle Ginestre Hospital, Palermo, Italy
- Fondazione Mondino Istituto Neurologico Nazionale a Carattere Scientifico IRCCS, Pavia, Italy
- Fondazione Serena ONLUS-Centro Clinico NEMO Trento, Pergine Valsugana, Italy
- Azienda Ospedaliera di Perugia, Perugia, Italy
- Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
- +4 more locations on ClinicalTrials.gov
Collaborators
University of Sydney · FightMND
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06126315 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGPHASE3NCT07322003Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPrilenia